logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

Dermira, Inc.

Calculating rank
USPTO Granted Patents = 16

% Expired Patents = 18.8



Trademarks = 1

Forward Citations = 56

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Anthony Adrian Shaw (14 out of 20 patents)

silverMedal Patricia Andres (8 out of 42 patents)

bronzeMedal John Allan Statler (8 out of 11 patents)

4.  Delphine Caroline Imbert (8 out of 15 patents)

5.  Jennifer Leigh Nelson (8 out of 26 patents)

6.  Lisa Lynn McQueen (8 out of 15 patents)

7.  Stephan Xander Mattheus Boerrigter (8 out of 12 patents)

8.  Mark Andres (6 out of 26 patents)

9.  Jon Gordon Selbo (6 out of 12 patents)

10.  Kanjai Khumtaveeporn (3 out of 4 patents)

11.  Pavel Krasik (3 out of 4 patents)

12.  Enrico Vigano (2 out of 3 patents)

13.  Renato Molteni (2 out of 3 patents)

14.  Laura Gleave (2 out of 2 patents)

15.  Ferda Cevikbas (2 out of 2 patents)


16 patents:

1. 12728117 - MrgprX2 antagonists for the treatment of inflammatory disorders (2026-09-08),
2. 12502380 - MrgprX2 antagonists for the treatment of inflammatory disorders (2025-12-23),
3. 10906871 - Processes for making, and methods of using, glycopyrronium compounds (2021-02-02),
4. 10548875 - Glycopyrrolate salts (2020-02-04),
5. 10543192 - Glycopyrrolate salts (2020-01-28),
6. 10294201 - Process for production of glycopyrronium tosylate (2019-05-21),
7. 10004717 - Glycopyrrolate salts (2018-06-26),
8. 9975867 - Synthetic process for preparing 2-furoic acid derivatives (2018-05-22),
9. 9926270 - Process for production of glycopyrronium tosylate (2018-03-27),
10. 9745277 - Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate (2017-08-29),
11. 9610278 - Glycopyrrolate salts (2017-04-04),
12. 9487497 - Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate (2016-11-08),
13. 9259414 - Glycopyrrolate salts (2016-02-16),
14. 9006462 - Glycopyrrolate salts (2015-04-14),
15. 9006461 - Crystalline glycopyrrolate tosylate (2015-04-14),
Company Overview
Dermira, Inc. is a biopharmaceutical company based in Menlo Park, California, focused on developing innovative therapies for dermatological conditions. The company specializes in addressing unmet medical needs in skin diseases, leveraging advanced research and technology to create effective treatments. Dermira's commitment to improving patient outcomes drives its research initiatives, which encompass a range of therapeutic areas within dermatology, aiming to enhance the quality of life for individuals suffering from various skin disorders.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

16 Patents

#90 in Menlo Park, CA

#4,778 in California

#19,944 in US

#37,887 in the World

Menlo Park, CA (US)
Menlo Park, CA, United States of America

Dermira, Inc.

Forward Citations = 56

19 inventors:

goldMedal Anthony Adrian Shaw (14 out of 20 patents)

silverMedal Patricia Andres (8 out of 42 patents)

bronzeMedal John Allan Statler (8 out of 11 patents)

4.  Delphine Caroline Imbert (8 out of 15 patents)

5.  Jennifer Leigh Nelson (8 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dermira, Inc.. Retrieved from https://idiyas.com/company/dermira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…